These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10516744)

  • 1. Severe hyperkalaemia due to the concomitant use of salt substitutes and ACE inhibitors in hypertension: a potentially life threatening interaction.
    Ray K; Dorman S; Watson R
    J Hum Hypertens; 1999 Oct; 13(10):717-20. PubMed ID: 10516744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine?
    Ahmed A
    J Am Geriatr Soc; 2002 Jul; 50(7):1297-300. PubMed ID: 12133029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperkalemia in ambulant postcardiac surgery patients during combined therapy with angiotensin-converting enzyme inhibitor, spironolactone, and diet rich in potassium: A report of two cases and review of literature.
    Dixit A; Majumdar G; Tewari P
    Ann Card Anaesth; 2019; 22(2):162-168. PubMed ID: 30971598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Life-threatening hyperkalaemia caused by ACE inhibitor and diuretics.
    Jarman PR; Keheley AM; Mather HM
    Diabet Med; 1997 Sep; 14(9):808. PubMed ID: 9300234
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe hyperkalaemia induced by trimethoprim in combination with an angiotensin-converting enzyme inhibitor in a patient with transplanted lungs.
    Bugge JF
    J Intern Med; 1996 Oct; 240(4):249-51. PubMed ID: 8918517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spironolactone + ace inhibitor or sartan: risk of hyperkalaemia.
    Prescrire Int; 2004 Apr; 13(70):58. PubMed ID: 15148978
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hyperkalemia as a limiting factor in the use of drugs that block the Renin Angiotensin Aldosterone System (RAAS)].
    Santoro A; Mandreoli M
    G Ital Nefrol; 2018 May; 35(3):. PubMed ID: 29786183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syncope caused by hyperkalemia during use of a combined therapy with the angiotensin-converting enzyme inhibitor and spironolactone.
    Erden I; Yalcin S; Ozhan H
    Kardiol Pol; 2010 Sep; 68(9):1043-5; discussion 1046. PubMed ID: 20859899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Life-threatening hyperkalaemia caused by angiotensin-converting enzyme-inhibitor and diuretics.
    Odawara M; Asano M; Yamashita K
    Diabet Med; 1997 Feb; 14(2):169-70. PubMed ID: 9047098
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk factors associated with a high velocity of the development of hyperkalaemia in hospitalised patients.
    Indermitte J; Burkolter S; Drewe J; Krähenbühl S; Hersberger KE
    Drug Saf; 2007; 30(1):71-80. PubMed ID: 17194172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperkalemia After Initiating Renin-Angiotensin System Blockade: The Stockholm Creatinine Measurements (SCREAM) Project.
    Bandak G; Sang Y; Gasparini A; Chang AR; Ballew SH; Evans M; Arnlov J; Lund LH; Inker LA; Coresh J; Carrero JJ; Grams ME
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28724651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperkalaemia in congestive heart failure patients using ACE inhibitors and spironolactone.
    Cruz CS; Cruz AA; Marcílio de Souza CA
    Nephrol Dial Transplant; 2003 Sep; 18(9):1814-9. PubMed ID: 12937229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone.
    Berry C; McMurray J
    Am J Med; 2001 Nov; 111(7):587. PubMed ID: 11705445
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial.
    Heerspink HJ; Gao P; de Zeeuw D; Clase C; Dagenais GR; Sleight P; Lonn E; Teo KT; Yusuf S; Mann JF
    Eur J Prev Cardiol; 2014 Mar; 21(3):299-309. PubMed ID: 24191305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
    J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which drugs affect potassium?
    Howes LG
    Drug Saf; 1995 Apr; 12(4):240-4. PubMed ID: 7646822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 cases.
    Schepkens H; Vanholder R; Billiouw JM; Lameire N
    Am J Med; 2001 Apr; 110(6):438-41. PubMed ID: 11331054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A patient with severe hyperkalaemia -- an emergency after RALES].
    Nürnberger J; Daul A; Philipp T
    Dtsch Med Wochenschr; 2005 Sep; 130(36):2008-11. PubMed ID: 16143930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid life-threatening hyperkalemia after addition of amiloride HCl/hydrochlorothiazide to angiotensin-converting enzyme inhibitor therapy.
    Chiu TF; Bullard MJ; Chen JC; Liaw SJ; Ng CJ
    Ann Emerg Med; 1997 Nov; 30(5):612-5. PubMed ID: 9360571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACE inhibitors and diuretics causing hypokalaemia.
    D'Costa DF; Basu SK; Gunasekera NP
    Br J Clin Pract; 1990 Jan; 44(1):26-7. PubMed ID: 2317435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.